oBservational clinical Research In chronic kidney disease patients with renal anemia :renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis stimulating agents,darbepoetiN alfa
Not Applicable
- Conditions
- Renal anemia in chronic kidney disease
- Registration Number
- JPRN-UMIN000013464
- Lead Sponsor
- iigata University Graduate School of Medical & Dental Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who are planning to start hemodialysis or renal transplantation within 24 weeks after enrolment; 2) Patients with a history of treatment with ESA except the ones who were treated temporarily more than 12 weeks before the enrollment; 3)Patients with malignant tumor, hematological disease, or hemorrhagic lesions; 4) Patients with hypersensitivity to ESA or any ingredient thereof; 5) Pregnant, lactating or possibly pregnant women or those who wish to be pregnant during the study period; 6) Patients who are participating in other clinical study; 7) Patients who are assessed as not eligible for the study by the investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Deterioration of renal function, Cardiovascular disease events
- Secondary Outcome Measures
Name Time Method